These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3156967)

  • 1. Tiapride in 12 Huntington's disease patients.
    Quinn N; Marsden CD
    J Neurol Neurosurg Psychiatry; 1985 Mar; 48(3):292. PubMed ID: 3156967
    [No Abstract]   [Full Text] [Related]  

  • 2. Tiapride in the treatment of Huntington's chorea.
    Roos RA; Buruma OJ; Bruyn GW; Kemp B; van der Velde EA
    Acta Neurol Scand; 1982 Jan; 65(1):45-50. PubMed ID: 6461156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptically induced dystonia in Huntington's disease: a case report.
    Schott K; Ried S; Stevens I; Dichgans J
    Eur Neurol; 1989; 29(1):39-40. PubMed ID: 2523309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of tiapride in patients with tardive dyskinesia and Huntington's disease.
    Roos RA; de Haas EJ; Buruma OJ; de Wolff FA
    Eur J Clin Pharmacol; 1986; 31(2):191-4. PubMed ID: 2948825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiapride versus placebo: a double-blind comparative study in the management of Huntington's chorea.
    Deroover J; Baro F; Bourguignon RP; Smets P
    Curr Med Res Opin; 1984; 9(5):329-38. PubMed ID: 6241563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cataplexy relieved by tiapride.
    Paulus W; Hömberg V; Noth J
    Arch Neurol; 1983 Dec; 40(13):828. PubMed ID: 6639414
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of neuroleptic treatment on involuntary movements and motor performances in Huntington's disease.
    Girotti F; Carella F; Scigliano G; Grassi MP; Soliveri P; Giovannini P; Parati E; Caraceni T
    J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):848-52. PubMed ID: 6147393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single oral dose pharmacokinetics of tiapride in patients with Huntington's disease.
    Norman T; Chiu E; James RH; Gregory MS
    Eur J Clin Pharmacol; 1987; 32(6):583-6. PubMed ID: 2958291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical neuroleptics: clozapine and the benzamides in the prevention and treatment of tardive dyskinesia.
    Pi EH; Simpson GM
    Mod Probl Pharmacopsychiatry; 1983; 21():80-6. PubMed ID: 6140635
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of permanent tardive dyskinesia with tiapride, a selective D2-receptor blocking agent.
    Leblhuber F
    Clin Neuropharmacol; 1987 Oct; 10(5):458-61. PubMed ID: 2902921
    [No Abstract]   [Full Text] [Related]  

  • 11. L-dopa-induced respiratory disturbance in Parkinson's disease suppressed by tiapride.
    De Keyser J; Vincken W
    Neurology; 1985 Feb; 35(2):235-7. PubMed ID: 3969212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of chorea (author's transl)].
    Ollat H
    Sem Hop; 1980 Jan 8-15; 56(1-2):49. PubMed ID: 6244629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiapride: effects on tardive dyskinesia and on prolactin plasma concentrations.
    Greil W; Auberger S; Haag H; Rüther E
    Neuropsychobiology; 1985; 14(1):17-22. PubMed ID: 3906426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the therapeutic range of tiapride in patients with tardive dyskinesia.
    Roos RA; Van der Velde EA; Buruma OJ; de Wolff FA
    J Neurol Neurosurg Psychiatry; 1986 Sep; 49(9):1055-8. PubMed ID: 3760895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiapride in the treatment of tardive dyskinesia.
    Buruma OJ; Roos RA; Bruyn GW; Kemp B; van der Velde EA
    Acta Neurol Scand; 1982 Jan; 65(1):38-44. PubMed ID: 6121443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tiapride in tardive dyskinesia.
    Pollak P; Gaio JM; Hommel M; Pellat J; Perret J
    Psychopharmacology (Berl); 1985; 85(2):236-9. PubMed ID: 3925489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amputation stump pain: a therapeutic study (author's transl)].
    Combes F
    Sem Hop; 1980 Feb 8-15; 56(5-6):245-7. PubMed ID: 6243795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiapride in levodopa-induced involuntary movements.
    Mejer Nielsen B
    Acta Neurol Scand; 1983 Jun; 67(6):372-5. PubMed ID: 6351529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of dyskinesias with tiapride (author's transl)].
    Kocher R; Hobi V
    Sem Hop; 1980 Dec 18-25; 56(47-68):2033-4. PubMed ID: 6109379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiapride versus glafenine: a double-blind comparative study in the management of acute rheumatic pain.
    Ginsberg F; Bourguignon RP; Smets P; Famaey JP
    Curr Med Res Opin; 1983; 8(8):562-9. PubMed ID: 6140128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.